ATX down-regulated MMP-1, MMP-2, and MMP-9, resulting in the inhibition of migration and invasion of melanoma cells in a dose-dependent manner from 5 – 125 μg/ml for 24 h (Chen et al., 2017). Here, MMP9 is linked to melanoma.